According to the Zhitong Finance App, Deqi Pharmaceutical-B (06996.HK) announced the interim results for the six months ended June 30, 2026. The group's revenue was 513 million yuan, up 864.75% year on year; net profit was 216 million yuan, which turned a year-on-year loss into a profit; and profit per share was 0.34 yuan.

According to the Zhitong Finance App, Deqi Pharmaceutical-B (06996.HK) announced the interim results for the six months ended June 30, 2026. The group's revenue was 513 million yuan, up 864.75% year on year; net profit was 216 million yuan, which turned a year-on-year loss into a profit; and profit per share was 0.34 yuan.